Bayer
Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. In line with its mission, “Health for all, Hunger for none,” the company’s products and services are designed to help people and the planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population.
Bayer is committed to driving sustainable development and generating a positive impact with its businesses. At the same time, the Group aims to increase its earning power and create value through innovation and growth. In fiscal 2023, the Group employed around 100,000 people and had sales of 47.6 billion euros. R&D expenses before special items amounted to 5.8 billion euros.
Company in the news
Deal strengthens the company’s position in crop protection and supports entry into the branded formulations business.
Deal expands Indian group’s reach in diamide insecticides and adds branded formulations.
Case over federal pesticide rules draws opposition from Democrats and “Make America Healthy Again” activists.
Bayer Crop Science Canada positions Sivanto Energy as an advanced option for early-season pest management.
Deal expands Summit Agro’s portfolio across Latin America, Asia-Pacific, and Canada.
New four-active formulation targets broader disease spectrum in pulse crops.
The company plans to launch commercially in the 2027/28 season, pending regulatory approvals.
UK decision allows applications on wheat and barley in successive seasons.
Bayer subsidiary loses appeal over PCB contamination at Washington state school.
Huskie PRE and Velocity m3 expand Bayer’s global portfolio of resistance-management solutions for cereals.
In focus
Stock quotes
Most read
Events
Live
About
